173
Participants
Start Date
December 31, 2008
Primary Completion Date
November 30, 2009
Study Completion Date
January 31, 2010
Menotropin
225 IU (up to 450 IU) by subcutaneous injection once per day for up to about 15 days until human chorionic gonadotropin (hCG) criteria are met.
Progestrone vaginal insert
100 mg progesterone vaginal insert 2 or 3 times daily (BID or TID) (start on the day after oocyte retrieval) until 10 weeks gestation or confirmation of negative pregnancy test.
follitropin beta
225 IU (up to 450 IU) by subcutaneous injection once per day for up to about 15 days until human chorionic gonadotropin (hCG) criteria are met.
Progesterone in oil
50 mg by intramuscular injection once per day, starting on the day after oocyte retrieval until 10 weeks gestation or confirmation of negative pregnancy test.
Ganirelix
Ganirelix acetate 250 µg as a daily subcutaneous injection starting on day 6 and continuing until hCG criteria were met.
Women's Medical Research Group, LLC, Clearwater
The Advanced IVF Institute; Charles E. Miller, MD & Associates, Naperville
A Woman's Center for Reproductive Medicine, Baton Rouge
Center for Assisted Reproduction, Bedford
Conceptions Reproductive Associates of Colorado, Littleton
Huntington Reproductive Center, Pasadena
San Diego Fertility Center, San Diego
Lead Sponsor
Ferring Pharmaceuticals
INDUSTRY